Aqilion
Pre-clinicalAqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care.
Founded
2017
Focus
Small Molecules
About
Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care.
Funding History
2Total raised: $20M
Series B$12MHadean VenturesMay 15, 2022
Series A$8MHadean VenturesOct 15, 2020
Company Info
TypePrivate
Founded2017
LocationHelsingborg, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile